LAUSANNE, Switzerland--Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc. (ALXN), today announced that the U.S. Food and Drug Administration (FDA) has granted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback